PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 27 June 2019, announced a new Peptide Drug Conjug...
Japanese company Takeda Pharmaceutical has announced the addition of five partners to its Global CSR programme for 2019,...
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...
Daiichi Sankyo Company, Limited and GE Healthcare have agreed that, Daiichi Sankyo will return the exclusive development...
US headquartered Gilead Sciences and Japan based Carna Biosciences has announced that the companies have entered in...
Japanese research-driven pharmaceutical company Shionogi & Co., Ltd., on 24 June 2019, announces that the Company ha...
Ricoh Company, Ltd., (Tokyo, Japan) has announced it has entered into a strategic business partnership with Elixirgen Sc...
Japan headquartered Toray has announced that a small size of TORAYMYXINTM (PMX-05R) had obtained EC certificate and is l...
Myriad Genetic Laboratories, a wholly-owned subsidiary of Myriad Genetics has announced the Japanese Ministry...
Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan has announced ...
Ricoh Company has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc. to deve...
Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrec...
Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYT...
Catalys Pacific, a new venture capital firm in Japan built by a global team seasoned in life sciences investin...
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has ...
Japan headquartered Terumo Corporation, a leading global medical device manufacturer has announced that it has secured e...
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies has announced it has licensed a ...
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...
